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Covalent bindingBackground: Overexpression of transferrin receptors (TfRs), which are responsible for the intracellular uptake of
ferric transferrin (Tf), has beendescribed in various cancers. Althoughmolecular biologymethods allow the iden-
tiﬁcation of different types of receptors in cancer cells, they do not provide features about TfRs internalization,
quantiﬁcation and distribution on cell surface. This information can, however, be accessed by ﬂuorescence tech-
niques. In thiswork, the quantum dots (QDs)' unique propertieswere explored to strengthen our understanding
of TfRs in cancer cells.
Methods: QDs were conjugated to Tf by covalent coupling and QDs-(Tf) bioconjugates were applied to quantify
and evaluate the distribution of TfRs in two human glioblastoma cells lines, U87 and DBTRG-05MG, and also in
HeLa cells by using ﬂow cytometry and confocal microscopy.
Results: HeLa and DBTRG-05MG cells showed practically the same TfR labeling proﬁle by QDs-(Tf), while U87
cells were less labeled by bioconjugates. Furthermore, inhibition studies demonstrated that QDs-(Tf) were able
to label cells with high speciﬁcity.
Conclusions: HeLa and DBTRG-05MG cells presented a similar and a higher amount of TfR than U87 cells. More-
over, DBTRG-05MG cells are more efﬁcient in recycling the TfR than the other two cells types.
General signiﬁcance: This is theﬁrst study about TfRs in human glioblastoma cells usingQDs. This new ﬂuorescent
tool can contribute to our understanding of the cancer cell biology and can help in the development of new ther-
apies targeting these receptors.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Transferrin (Tf) is a β-globin with approximately 670–700 amino
acids, which binds to a cell surface receptor (TfR) expressed by most
proliferating cells with particularly high expression on tumor cells,
being one of the biomolecules most applied to cancer cell targeting
[1]. The TfR is also known as CD71 and promotes the cellular uptake of
ferric Tf [2], by clathrin-mediated endocytosis [3]. Nanotechnology
approaches have taken advantage of the potential use of the TfRs to
improve therapy and diagnostic procedures related to cancer. The
most common systems employed for these purposes are liposomes
[4,5], metallic nanoparticles [6,7] and magnetic nanoparticles [3].. Departamento de Biofísica e
. Fontes).These nanosystems have been functionalized with Tf to target the
TfR in order to improve diagnostic methods, as well as the efﬁcacy
of chemotherapeutics, since cancer cells and tissues overexpress
TfR on their surface with respect to normal cells. Zhai et al. [4], for in-
stance, used TfRs as targets of liposomes conjugated to Tf and loaded
with docetaxel, showing that these nanocarriers are a promising
chemotherapeutic delivery vehicle for cancer therapeutics, when
compared to liposomes lacking Tf. Therefore, studies related to the
TfR can provide a better understanding of the cell biology of cancer
and also help to improve its treatment.
TfRs have been widely studied by molecular biology approaches,
which proved to be a valuable tool in the identiﬁcation of different
types of receptors in cancer cells [8–10]. However, molecular biology
methods do not provide information about the cellular internalization
of the receptor, its quantiﬁcation and distribution. Fluorescence-based
techniques have high sensitivity to quantify biomolecules with
Fig. 1. Optical characterization of CdTe QDs aqueous colloidal suspension: absorption
(dashed line) and emission (solid line) spectra. The excitation wavelength (λexc) for the
emission spectrum was 365 nm.
Table 1
FluorescenceMicroplate Assay results obtained from the average signal ofﬂuorescence in-
tensities (controls and bioconjugates) and percentage of relative ﬂuorescence intensity of
the bioconjugates.
Systems Average of signal
4 days
RF (%) 4
days
Average of signal
10 days
RF (%) 10
days
Transferrin 151.6 – 122.6 –
QDs 212.0 – 258.0 –
QDs-(Tf) 698.0 283.9 41,615.0 21,764.0
29P.E. Cabral Filho et al. / Biochimica et Biophysica Acta 1860 (2016) 28–35high speciﬁcity and thus can be used as innovative and attractive
methods to investigate receptor intracellular trafﬁcking and distri-
bution, complementing molecular biology studies [11]. Among the
most promising probes that can be applied in ﬂuorescence-based
research are the quantumdots (QDs), which are semiconductor ﬂuores-
cent nanoparticles that have great potential for biological research due
to their unique optical and chemical properties. QDs present exception-
al resistance to photobleaching, enabling long-term studies, and their
active surface allows their functionalization with biomolecules in
order to reach biological targets with a high speciﬁcity [12–15]. These
QDs' features can be employed to strengthen our understanding of
cellular receptors, such as the TfR.
The aim of this work was to apply CdTe QDs conjugated to Tf
(QDs-Tf) as probes to study the TfRs in human glioblastoma cells,
by using the complementary analyzes provided by ﬂuorescence con-
focal microscopy and ﬂow cytometry. The TfR was quantiﬁed and its
distribution was analyzed in two different human glioma cells lines,
U87 (glioblastoma) and DBTRG-05MG (recurrent glioblastoma).
HeLa cells (human epithelial cervical carcinoma)were used as a control
cellularmodel in thiswork, since QDs associated to Tf have already been
applied to study the TfR in these cells [16–19]. However, the speciﬁcity
of such conjugates has not been fully proved in those previous works.
Here, the bioconjugation procedure of QDs to Tf was improved and
the speciﬁcity of the labeling was demonstrated by TfR saturation
assays. Moreover, to our knowledge, this is the ﬁrst study that notFig. 2. Emission spectra of bare QDs (solid line) and QDs-(Tf) (dashed line). Pictures of the
QDs (orange emission) and the bioconjugates (red emission) show their ﬂuorescence
under UV–Vis excitation (λexc = 365 nm).only investigates the TfR in these two glioblastoma cell lines, but also
compares the amount and the distribution of TfRs on these types of
tumor cells, using the HeLa cell line as reference.Fig. 3. Confocal microscopy images of HeLa cells labeled by QDs-(Tf). (A) Control HeLa
cells, (B) HeLa cells incubated with bare QDs, (C) HeLa cells incubated with QDs-(Tf) and
(D) HeLa cells incubated with QDs-(Tf) after TfR saturation. The identiﬁcation (1) refers to
the confocal emission channel LP 565 nm and the identiﬁcation (2) refers to the overlap of
LP 565 nm and Hoechst emission channel (BP 420-480 nm). Scale Bar: 20 μm.
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2.1. Synthesis and characterization of CdTe-MSA QDs
CdTe-MSA QDs were synthesized as an aqueous colloidal dispersion
according to a previously reported method, with some modiﬁcations
[20]. Brieﬂy, QDs were prepared by adding Te2− ions to a Cd(ClO4)2
solution at pH N 10 in the presence of MSA (mercaptosuccinic acid) as
stabilizing agent in a molar ratio of 5:1:6 (Cd:Te:MSA, respectively).
The Te2− aqueous solutionwas prepared by reducingmetallic tellurium
with NaBH4 at a high pH and under nitrogen saturated inert atmo-
sphere. The reaction proceeded under constant stirring and heating at
90 °C during 5 h.
After their synthesis, QDswere optically characterized by absorption
and emission spectroscopy carried out on a spectrophotometer
Evolution 600 UV–Vis (Thermo Scientiﬁc) and on spectrometer LS 55
(PerkinElmer, at λexc = 365 nm), respectively.
2.2. CdTe-MSA QDs conjugation to transferrin
CdTe-MSA QDs were conjugated with human holo transferrin (Tf)
(Sigma Aldrich) by using N-ethyl-3-(3-dimethylaminopropyl)carbo
diimide hydrochloride (EDC — Fluka) and N-hydroxysulfosuccinimide
sodium salt (Sulfo-NHS — Sigma Aldrich) as coupling reagents.
First, the pH of 2 mL of the CdTe-MSA QDs dispersion (at 0.84 μM)
was adjusted to 5.5 by using MSA at 4.9% (w/v). Then, 1 mL of EDC
(at 4 mg·mL−1) was added and after 5 min, 1 mL of Sulfo-NHS (at
5.5 mg·mL−1) was also added to the QDs aqueous suspension [21,22].
Then, 15 min later, 194 μL of Tf (at 1 mg·mL−1) was added to reach a
ratio of QDs:Tf 1:2 (particle:molecule).
Before cell labeling, the QDs-(Tf) conjugated systemwas incubat-
ed with 50 μL of TRIS base (at 1 mM) for 2 h under slow agitation.
This procedure was used to quench the free carboxyl groups of
non-conjugated QDs in order to minimize unspeciﬁc labeling. QDs-
(Tf) were optically characterized by emission spectroscopy at
λexc = 365 nm by using the same spectrometer mentioned above
(LS 55, PerkinElmer).Fig. 4. Flow cytometry analysis of HeLa cells. In (A) HeLa cells in PBS, (B) HeLa cells incubat
with QDs-(Tf) after Tf-receptor saturation.2.3. Conﬁrmation of conjugation QDs-(Tf) by Fluorescence Microplate
Assay (FMA)
To conﬁrm the efﬁciency of the bioconjugation process, we
employed the Fluorescence Microplate Assay (FMA) [23]. Brieﬂy,
all the systems (Tf, bare QDs and QDs-(Tf)) were placed in a polysty-
rene microplate (black 96-well Optiplate F HB microplates —
PerkinElmer) in triplicates, at the same concentration used for the
bioconjugation assay. The plate was maintained for 2 h in an incubator
(water bath, humid chamber) at 37 °C. After this period, the plate was
washed three times with a phosphate buffered saline solution, PBS 1×
(from now on named as PBS).We analyzed the conjugates as a function
of time by evaluating the QDs-(Tf) samples at 4th and 10th days after the
initial bioconjugation assay.
Fluorescence measurements were performed on a WALLAC 1420
Plate Reader, equippedwith the software Victor2 (PerkinElmer). The ex-
citation band passﬁlter usedwas the BP 405nm±2.5 nmand the emis-
sion band pass ﬁlter was the BP 595 nm± 15 nm. The acquisition time
was 1 s, the lamp was set to 20,000 and normal slits were used for the
excitation of samples and for collecting the emission.
2.4. Cell culture
HeLa cells (human epithelial cervical carcinoma) were obtained
from the American Type Culture Collection (Manassas, VA, USA) and
the U87 (human glioblastoma) and DBTRG-05MG (human recurrent
glioblastoma) cells were kindly provided by Dr. Peter Canoll (Columbia
University, New York, NY) and Dr. Massimiliano Salerno (Siena Biotech,
Italy). HeLa and U87 cells were cultured in Dulbecco's modiﬁed Eagle's
medium with high glucose (DMEM — Sigma Aldrich) supplemented
with 10% of fetal bovine serum (FBS — Gibco), 100 mg·mL−1 strepto-
mycin and 100 units·mL−1 penicillin (Sigma Aldrich) at 37 °C in a
humidiﬁed atmosphere with 5% CO2. DBTRG-05MG cells were cultured
in Roswell Park Memorial Institute (RPMI — Sigma Aldrich) 1640
medium supplemented with 10% of FBS, 100 mg·mL−1streptomycin
and 100 units·mL−1 penicillin at 37 °C in a humidiﬁed atmosphere
with 5% CO2. When HeLa cells reached 90% conﬂuence in the cultureed with bare QDs (C) HeLa cells incubated with QDs-(Tf) and (D) HeLa cells incubated
31P.E. Cabral Filho et al. / Biochimica et Biophysica Acta 1860 (2016) 28–35ﬂask, they were detached with 0.25% of trypsin (Sigma Aldrich) in
Dissociation Buffer (Gibco). Detachment of U87 and DBTRG cells was
performed exclusively with Dissociation Buffer. The cells were then
seeded onto a 6-well plate (1.5 x 105 cells/well — Thermo Scientiﬁc™
BioLite) and incubated for 24 h for ﬂow cytometry studies and in an
8-well plate (2.0 × 104 cells/well— μSlide IbiTreat, Germany) for confo-
cal microscopy analysis. At this time point, cells exhibited a conﬂuence
of around 80–90% in the wells.
2.5. Labeling cancer cells with QDs-(Tf)
After incubation for 24 h in 6-well or 8-well plates, the cells were
washed with PBS and the following experimental conditions were
assayed: (I) control cells with PBS; (II) PBS and bare QDs (1:1 v/v); (III)
PBS and QDs-(Tf) (1:1 v/v). After 1 h of incubation at 37 °C, the cells
were washed with PBS before ﬂow cytometry and confocal microscopy
analysis to remove any residual labeling on the cell surface by bare QDs.
The percentage of labeled cells was determined by ﬂow cytometry
(FACSCalibur™, Becton Dickinson). In these studies, HeLa cells were
detached from the 6-well plate upon incubation with trypsin 0.25%
in Dissociation Buffer followed by trypsin inactivation with DMEM
and then placed in suspension. U87 and DBTRG cells were detached
exclusively with Dissociation Buffer. The cell suspensions wereFig. 5. Flow cytometry analysis of HeLa cells following incubation at 4 °C. (A) HeLa cells in
PBS, (B) HeLa cells incubated with bare QDs, and (C) HeLa cells incubated with QDs-(Tf).washed 3 times with PBS and pelleted by centrifugation at
1200 ×g, 30 s (MiniSpin — Eppendorf). Around 20,000 events were
acquired for each experimental condition following excitation at
488 nm. The emission was detected with the band pass ﬁlter 585/
20 nm and the collected data were processed by the Cell Pro Software
(Cell Quest™, Becton-Dickinson).
For confocal analysis, and following the establishment of different ex-
perimental conditions, the cells plated onto 8-well plates were washed
three timeswith PBS. The cell nucleiwere stained for 5minwith the ﬂuo-
rescent DNA-binding dye Hoechst 33,342 (at a ﬁnal concentration of
1 μg·mL−1), and the cells were washed with PBS three times before
being observed under a confocal microscope (Zeiss LSM 510 META).Fig. 6. Confocal microscopy images of U87 cells labeled by QDs-(Tf). (A) Control U87 cells,
(B) U87 cells incubatedwith bare QDs, (C) U87 cells incubatedwith QDs-(Tf) and (D) U87
cells incubated with QDs-(Tf) after TfR saturation. The identiﬁcation (1) refers to the con-
focal emission channel LP 565 nm and the identiﬁcation (2) refers to the overlap of LP
565 nm and Hoechst emission channel (BP 420-480 nm). Scale Bar: 20 μm.
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ciency of the bioconjugation, cells were also incubated with excess of
free human holo transferrin (at a ﬁnal concentration of 10 mg·mL−1)
for 1 h at 37 °C, aiming at saturating the TFRs [24], before the confocal
analysis. After this period, the cells were incubated with QDs-(Tf) for
1 additional hour at a ﬁnal QDs-(Tf): free Tf ratio of 1:1 (v/v).
3. Results and discussion
3.1. Characterization of CdTe QDs and bioconjugates
According to optical characterizations, MSA QDs aqueous suspen-
sion presented a ﬁrst maximum absorption peak at 548 nm, as can be
observed in Fig. 1. By using the Dagtepe et al. [25] equation and the
Rogach et al. [26] approximation, we estimated an average diameter
of approximately 3.1 nm for these nanoparticles. Furthermore, taking
into account the absorbance at the ﬁrst maximum absorption peak,
the CdTe QDs molar extinction coefﬁcient proposed by Yu et al., [27]
and the Lambert-Beer equation, we also estimated the QDs concentra-
tion as approximately 4.8 μM. The QDs colloidal suspension showed
an emission maximum at 602 nm and a full width at a half maximum
(FWHM) of about 58 nm, indicating a narrow emission spectrum
(Fig. 1) which is ascribed to the exciton recombination.
Bare QDs and QDs-(Tf) (bioconjugates) exhibited similar emission
spectra proﬁles for emission spectra (Fig. 2, λexc = 365 nm), however
QDs-(Tf) showed a maximum emission at 626 nm. The observed red
shift for the QDs-(Tf) suggests modiﬁcations on the QDs surface due to
the bioconjugation process. The same behavior was observed in previ-
ous works using hydrophilic QDs conjugated to Concanavalin A [28]
and to Ulex europaeus lectins [29]. In both cases the red shift of the
emission peak was observed. Despite the red shift, QDs bioconjugates
suspension remained highly ﬂuorescent, as shown in Fig. 2.
3.2. Fluorescence Microplate Assay
The FMA results are presented in Table 1 as the average of the ﬂuo-
rescent signal of triplicate wells for controls and conjugates. The dataFig. 7. Flow cytometry analysis of U87 cells. (A) U87 cells in PBS, (B) U87 cells incubated with b
after TfR saturation.analysis was carried out according to Carvalho et al. [23]. The relative
ﬂuorescence (RF) results for QDs-(Tf) were 283.9% and 21,764.0%, for
the 4th and 10th days after bioconjugation, respectively. According to
Carvalho et al. [23] the bioconjugation process is efﬁcient when the bio-
conjugates show a RF higher than 100%. Therefore, our results (Table 1)
indicate that the bioconjugation was efﬁcient after four days and im-
proved over time. The Sigma Aldrich product information indicates
that Tf should remain active at 4 °C for 5–10 days after dilution.
3.3. Labeling HeLa cells by using QDs-(Tf)
As shown in Fig. 3, efﬁcient and speciﬁc labeling of the TfR was
observed in HeLa cells using QDs-(Tf) (Fig. 3, C1 and C2). HeLa
cells, incubated with bare QDs (Fig. 3, B1 and B2), as well as after
TfR saturation by free Tf (Fig. 3, D1 and D2), did not show considerable
labeling, resulting in an image proﬁle similar to the one obtained for
control (in the absence of QDs) HeLa cells (Fig. 3, A1 and A2). The use
of the DNA-binding dye Hoechst allowed to detect the intracellular lo-
calization of the receptor, indicating that 1 h of cell incubation with
the QDs-(Tf) was sufﬁcient to promote the internalization of the TfR
by HeLa cells.
The confocal microscopy results were conﬁrmed by ﬂow cytometry
analysis. As shown in Fig. 4C, about 94% of HeLa cells were labeled by
QDs-(Tf), while incubation of the cells with bare QDs (Fig. 4B) or after
inhibiting the speciﬁc interaction of QDs-(Tf)with TfRs (Fig. 4D), result-
ed in less than 26% of cell labeling. The residual labeling, less than 26%,
may be attributed to QDs internalization by a TfR-independent path-
way. This type of unspeciﬁc interaction between the cells and nanopar-
ticles has been previously reported [30–32].
These results were conﬁrmed by incubating the cells at 4 °C (Fig. 5),
under which conditions endocytosis is compromised [33]. As shown in
Fig. 5B, HeLa cells labeling by bare QDs was inhibited. On the other
hand, QDs-(Tf) labeled 50.5% of HeLa cells (Fig. 5C) corresponding to
the labeling of TfRs that remained on the cell surface, since the receptors
cannot be internalized at this temperature, resulting in a decrease of la-
beled cells of approximately 43%, when compared to what was ob-
served at 37 °C (Fig. 4C). Therefore, our results demonstrated speciﬁcare QDs (C) U87 cells incubated with QDs-(Tf) and (D) U87 cells incubated with QDs-(Tf)
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tion of the QDs-(Tf).
In this work, HeLa cells were used as a model cell system and exper-
imental approaches involving the blocking of TfR or inhibition of TfR-
mediated endocytosis were employed to conﬁrm the efﬁciency and
speciﬁcity of QDs-(Tf) conjugates. Indeed, although the TfR has been
studied by ﬂuorescence assays with QDs [16,18,34,35], the targeting
speciﬁcity of such conjugates has not been fully demonstrated. Sahoo
et al. used polymeric nanoparticles (NPs) conjugated to Tf and showed
that when NPs-Tf were incubated with an excess of Tf (50 μg), the per-
centage of labeled MCF-7 cells (a breast cancer cell line) was similar to
that obtained when the cells were incubated with bare NPs [36].
These results are in agreementwith our ﬁndings showing the speciﬁcity
of the TfR labeling byQDs-Tf in HeLa cells. In this regard, less than23% of
HeLa cells were labeled after TfR saturation (Fig. 4D), this labeling being
most likely attributed to QDs-(Tf) non-speciﬁc endocytosis, consistent
with the results observed when HeLa cells were incubated with bare
QDs, which do not exhibit afﬁnity to TfR (Fig. 4B). To our knowledge,
this is the ﬁrst study addressing TfR saturation through competitive in-
hibition experiments with free Tf to conﬁrm that the cell internalization
of QDs-(Tf) bioconjugates is speciﬁc for TfRs.
Our results showed that 1 h of incubation with QDs-(Tf) was sufﬁ-
cient to promote their internalization through speciﬁc interaction with
TfRs in HeLa cells. These achievements agree with those presented by
Chan et al. and Tekle et al. that applied QDs-(Tf) to label speciﬁcally
the TfR in HeLa cells [16,19]. Guan et al. carried out three different
types of conjugations by usingQDs and Tf, and showed that themost ef-
ﬁcient was the one using EDC as coupling agent [18]. The authors dem-
onstrated that approximately 85.5% of cells were labeled by QDs-Tf. Our
results using EDC and Sulfo-NHS presented an improvement relative to
these previous studies, showing a labeling percentage of about 93%. To
our best knowledge, this is the ﬁrst work that used EDC and Sulfo-
NHS simultaneously as coupling agents to conjugateMSA-QDs to Tf. Ac-
cording to Hermanson [22], the simultaneous use of these coupling
agents improves the bioconjugation process by minimizing the genera-
tion of reactive species, when compared to the individual use of EDC for
bioconjugation purposes.Fig. 8. Confocal microscopy images of DBTRG-05MG cells labeled by QDs-(Tf). (A) Control
DBTRG-05MG cells (B) DBTRG-05MG cells incubated with bare QDs, (C) DBTRG-05MG
cells incubated with QDs-(Tf) and (D) DBTRG-05MG cells incubated with QDs-(Tf) after
TfR saturation. The identiﬁcation (1) refers to the confocal emission channel LP 565 nm
and the identiﬁcation (2) refers to the overlap of LP 565 nm and Hoechst emission chan-
nel (BP 420-480 nm). Scale Bar: 20 μm.3.4. Labeling glioblastoma cells by using QDs-(Tf)
In studies addressing the TfR in glioblastoma cells, we employed the
U87 human glioblastoma cell line, extensively reported as a relevant
glioblastoma cellular model and the DBTRG-05MG cell line, established
from a glioblastoma patient treated with local brain irradiation and
multidrug chemotherapy. Confocal microscopy images of U87 cells,
displayed in Fig. 6, show that the TfR is present in a minimal amount,
since a very small amount of labeling could be observed following incu-
bation with QDs-(Tf) (Fig. 6, C1 and C2). Blocking Tf-receptor by adding
excess of free Tf decreased even further the cell labeling (Fig. 6, D1 and
D2), and similar results were obtained after cell incubation with bare
QDs (Fig. 6, B1 and B2).
The confocal microscopy results were conﬁrmed by quantitative
ﬂow cytometry analysis of U87 cells, as illustrated in Fig. 7. Fig. 7C
shows that 57.0% of U87 cells were labeled when incubated with QDs-
(Tf). On the other hand, only 25.5% of cells were labeled after TfR satu-
ration (Fig. 7D).
According to Dixit et al. [7], when U87 cells were incubated with
gold nanoparticles functionalized by the Tf peptide, an accumulation
of these nanostructureswas observed inside the cells after 1 h,which in-
creased until 24 h. The results of that study indicated that the endocytic
activity of U87 cells occurs at a slower rate when compared to that of
LN299 cells, another human glioma cell line, with an uptake plateau
after 1 h. In agreement with the ﬁndings reported by Dixit et al., our re-
sults showed that U87 cells internalize QDs-(Tf) at a low extent which
also seem to have a small amount of TfRs at the plasma membrane.In contrast with U87 cells, confocal microscopy images of DBTRG-
05MG cells incubated with QDs-(Tf) (Fig. 8, C1 and C2) showed that
TfR internalization was very effective in these cells. After 1 h incubation
with QDs-(Tf), DBTRG-05MG cells showed a similar proﬁle to that in
HeLa cells, regarding the presence of the TfR (Fig. 8C and Fig. 3C, respec-
tively). Furthermore, when DBTRG-05MG cells were incubated with
bare QDs (Fig. 8, B1 and B2) no signiﬁcant unspeciﬁc labeling was ob-
served. However, when these cells were incubated with QDs-(Tf),
after TfR saturation with free Tf (Fig. 8, D1 and D2), ﬂuorescent labeling
in some cells was detected.
Fig. 9. Flow cytometry analysis in DBTRG-05MG cells. (A) DBTRG-05MG cells in PBS, (B) DBTRG-05MG cells incubatedwith bare QDs, (C) DBTRG-05MG cells incubatedwith QDs-(Tf) and
(D) DBTRG-05MG cells incubated with QDs-(Tf) after TfR saturation.
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through ﬂow cytometry analysis (Fig. 9). Approximately 93% of
DBTRG-05MG cells were positively labeled after 1 h incubation with
QDs-(Tf) (Fig. 9C), indicating that these cells express a high amount of
TfRs. However, when the cells were incubated with bare QDs, a signiﬁ-
cant decrease in the percentage of labeled cells was observed to about
26% (Fig. 9B). Furthermore, when the TfR was blocked by addition of
excess free Tf, 69.2% of DBTRG-05MG cells still presented labeling by
QDs-(Tf) (Fig. 9D), corroborating the observationsmade by confocalmi-
croscopy. Taken together, these results denote a more efﬁcient TfR
recycling in these cells as compared to U87 or HeLa cells, which can be
attributed to a higher metabolic activity of DBTRG-05MG cells [37].
Asmentionedbefore, theDBTRG-05MG cell linewas originated from
the tumor tissue of a patient owing a recurrent glioblastoma that has
been treated with irradiation and chemotherapy [38]. This variant of
glioblastoma is more aggressive and resistant to current chemotherapy
when compared to that originated from U87 cells [39–41], which can
also justify the high metabolic rate and the probably faster recycling of
the TfR observed in DBTRG-05MG cells.
Moreover, our results demonstrate that HeLa and DBTRG-05MG
cells express and internalize comparable amounts of TfRs, showing
94% and 93% of cells labeled by QDs-(Tf), respectively, while U87 cellsFig. 10. Confocal microscopy images comparing HeLa, U87 and DBTRG-05MG cells following
420–480 nm emission and DIC. (A) HeLa cells, (B) U87 cells and (C) DBTRG-05MG cells. Scalepresent a lower quantity of TfRs, associated to a lower extent of internal-
ization of these receptors, resulting in 57% of cells labeled by QDs-(Tf).
Fig. 10 shows comparative confocal microscopy images of the three
cell lines, HeLa (Fig. 10A), U87 (Fig. 10B) and DBTRG-05MG (Fig. 10C),
after incubation with QDs-(Tf). As observed, after 1 h of incubation,
TfRs are accumulated inside HeLa and DBTRG-05MG cells in endocytic
vesicles, indicating an efﬁcient uptake of these receptors. This kind of in-
ternalization proﬁle has already been reported previously in HeLa cells
[16,19,35]. On the other hand, U87 cells (Fig. 10B) present a lower
amount of TfRs, and the conjugates seem to be preferentially located
at the cell membrane level, suggesting a lower endocytosis extent
when compared to HeLa or DBTRG-05MG cells.
4. Conclusions
QDs-(Tf) were used in this work to quantify the expression and study
the trafﬁc of the TfRs in different types of mammalian cancer cells. HeLa
and DBTRG-05MG cells present a similar amount of TfR, while U87 cells
demonstrated to have a lower quantity of this receptor, when compared
to the other two cell lines. Furthermore, DBTRG-05MG cells were more
efﬁcient in promoting the recycling of TfRs than HeLa or U87 cells. There-
fore, this work suggests that a speciﬁc chemotherapeutic drug deliverylabeling by QDs-(Tf). These micrographs are overlaps of the confocal ﬁlters: LP 565, BP
bar: 20 nm.
35P.E. Cabral Filho et al. / Biochimica et Biophysica Acta 1860 (2016) 28–35system targeting TfRs could be more effective in DBTRG-05MG and HeLa
cancer cells than in U87. This is an interesting result, particularly taking
into consideration the fact that DBTRG-05MG cells are originated from a
recurrent glioblastoma, while U87 cells derive from a primary tumor,
which suggests that TfRs may play an important role in cancer cell main-
tenance in recurrent situations.
Overall, the results presented in this study illustrate that QDs-(Tf)
can be applied to quantify TfR expression and also to study the dynam-
ics of this receptor in different types of cancer cells. Therefore, we be-
lieve that this biophotonic tool can be of great value in future studies
in cancer cell biology. The understanding of the molecular aspects of
cancer cell biology can help to develop new and effective therapies for
this disease, such as those targeting TfRs as a speciﬁc and efﬁcient
entry pathway for chemotherapeutic drugs.
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